MEK , 0 Comments

The consequences of pharmacological hypoxia-inducible factor (HIF) stabilization were investigated in the MMTV-Neundl-YD5 (NeuYD) mouse style of breast cancer. ([PHD2] P317R, R371H).11,12 These provide genetic proof that modulation of HIF pathway genes may be used to boost RBC mass. Research of pVHL-mutated Chuvash polycythemia individuals have not demonstrated improved tumor predisposition.13 In comparison, additional mutations

Read More